Association of αS-SAA kinetics with clinical scores in the clinical spectrum of Parkinson's disease
{{output}}
BackgroundCerebrospinal fluid (CSF) α-synuclein seed amplification assay (αS-SAA) is a recognized biomarker of synucleinopathy. In Parkinson's disease (PD), its potential for predicting clinical outcome needs to be further assessed.ObjectiveTo evaluate the ... ...
